General Biologicals

General Biologicals EBIT per Share

The EBIT per Share of General Biologicals (4117.TWO) as of Oct 31, 2026 is -3.65 TWD. In the previous year, EBIT per Share was -3.56 TWD — a change of 2.45% (lower).

EBIT per Share

-3.65TWD

YoY

2.45%

Last updated:

EBIT per Share of General Biologicals is 2025 -3.65 TWD. EBIT per Share of General Biologicals was 2024 -3.56 TWD. It decreases by 2.45% lower compared to the previous year.

The General Biologicals EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-1.42 TWD
Jan 1, 2019
-0.58 TWD
Jan 1, 2020
0.72 TWD
Jan 1, 2021
0.73 TWD
Jan 1, 2022
-0.68 TWD
Jan 1, 2023
-2.84 TWD
Jan 1, 2024
-3.56 TWD
Jan 1, 2025
-3.65 TWD
The General Biologicals EBIT per Share history
YEAREBIT per ShareYoY
-3.65TWD+2.45%
-3.56TWD+25.43%
-2.84TWD+315.79%
-0.68TWD-193.33%
0.73TWD+0.98%
0.72TWD-225.57%
-0.58TWD-59.32%
-1.42TWD-32.22%
-2.09TWD-6.40%
-2.24TWD+8.28%
-2.07TWD+168.98%
-0.77TWD+1,547.87%
-0.05TWD-56.01%
-0.11TWD-55.38%
-0.24TWD-415.10%
0.08TWD-137.53%
-0.20TWD-30.20%
-0.29TWD+251.53%
-0.08TWD-95.79%
-1.94TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

General Biologicals Stock analysis

What does General Biologicals do? General Biologicals Corp., headquartered in Baoshan, Hsinchu, Taiwan, operates in the Health Care sector, specifically within the Biotechnology industry. The company engages in research, development, manufacturing, and trading of diagnostics, pharmaceuticals, and medical supplies. Its main products include detection reagents, biological protein new drugs, P113, and medical supplies, distributed domestically and internationally. Listed on 4 July 2002, the company employs 63 people. General Biologicals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about General Biologicals stock

EBIT per Share of General Biologicals is -3.65 TWD in 2025.

EBIT per Share of General Biologicals changed from -3.56 TWD to -3.65 TWD, representing a 2.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share General Biologicals since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — General Biologicals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — General Biologicals